Steris (STE)

• Market cap: $21.7B
• 1 day: -0.10%
• 5 days: 0.03%
• 1 month: 1.61%
• 3 months: 2.22%
• 6 months: -5.90%
• Year to date: 8.94%
• 1 year: -5.28%
• 5 years: 31.32%
• 10 years: 236.53%
• Sector: Healthcare
• Industry: Orthopedic, Prosthetic & Surgical Appliances & Supplies

About: Steris is an Ireland-domiciled medical technology company focused on sterilization services and infection prevention. The company is the global leader in contract sterilization services, ensuring the safe delivery of single-use and implantable medical equipment to hospitals around the world. Additionally, Steris sells sterilizers, washer-disinfectors, and other decontamination equipment and supplies for use by care provider facilities and in biopharma manufacturing sites. Domiciled in the United States before its inversion to Ireland, the firm derives approximately 70% of its revenue from Healthcare Services, 19% from Applied Sterilization Technologies, or AST, and 11% from life sciences services after the divestment of its dental products business.

Employees: 18,179

Fund manager confidence

Based on 2024 Q4 regulatory filings by fund managers ($100M+ AUM)

436% more call options, than puts

Call options by funds: $8.59M | Put options by funds: $1.6M

12% more first-time investments, than exits

New positions opened: 86 | Existing positions closed: 77

2% less funds holding

Funds holding: 749 [Q3] → 735 (-14) [Q4]

2.86% less ownership

Funds ownership: 95.4% [Q3] → 92.54% (-2.86%) [Q4]

13% less funds holding in top 10

Funds holding in top 10: 8 [Q3] → 7 (-1) [Q4]

15% less repeat investments, than reductions

Existing positions increased: 251 | Existing positions reduced: 297

17% less capital invested

Capital invested by funds: $22.5B [Q3] → $18.8B (-$3.76B) [Q4]

Research analyst outlook

3 Wall Street Analysts provided 1 year price targets over the past 3 months

• Low target: $240 9% upside
• Avg. target: $257 16% upside
• High target: $265 20% upside

3 analyst ratings

• positive: 3 100%
• neutral: 0 0%
• negative: 0 0%

JMP Securities Reni Benjamin 14% 1-year accuracy 5 / 37 met price target	20% upside $265	Market Outperform Reiterated	6 Feb 2025
Stephens & Co. Jacob Johnson 19% 1-year accuracy 3 / 16 met price target	9% upside $240	Overweight Reiterated	6 Feb 2025
Piper Sandler Jason Bednar 45% 1-year accuracy 17 / 38 met price target	20% upside $265	Overweight Maintained	3 Feb 2025